Virtual reality as a strategy for intra-operatory anxiolysis and pharmacological sparing in patients undergoing breast surgeries: The V-RAPS randomized controlled trial protocol.

<h4>Introduction</h4>Virtual reality (VR) has increasingly found applications beyond leisure and video games, extending into the field of medicine. Recent studies indicate that VR can effectively reduce anxiety and pain in pediatric patients undergoing uncomfortable medical procedures, s...

Full description

Saved in:
Bibliographic Details
Main Authors: Joe Zako, Nicolas Daccache, Julien Burey, Ariane Clairoux, Louis Morisson, Pascal Laferrière-Langlois
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0327555
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850113506353872896
author Joe Zako
Nicolas Daccache
Julien Burey
Ariane Clairoux
Louis Morisson
Pascal Laferrière-Langlois
author_facet Joe Zako
Nicolas Daccache
Julien Burey
Ariane Clairoux
Louis Morisson
Pascal Laferrière-Langlois
author_sort Joe Zako
collection DOAJ
description <h4>Introduction</h4>Virtual reality (VR) has increasingly found applications beyond leisure and video games, extending into the field of medicine. Recent studies indicate that VR can effectively reduce anxiety and pain in pediatric patients undergoing uncomfortable medical procedures, such as burn wound care. Yet, VR use in the operating room is still rare, despite a growing trend toward regional anesthesia without general anesthesia; physicians still frequently rely on pharmacological sedation to manage procedural anxiety. By leveraging VR's anxiolytic properties, it may be possible to decrease the need for intravenous (IV) sedation which is associated with risk of adverse events like apnea and hypoxemia and delayed recovery.<h4>Objectives</h4>This study's main objective is to determine the impact of VR on IV sedation requirements in adult patients undergoing breast surgery under paravertebral (PV) block without general anesthesia. We will be using Paperplane Therapeutics' VR headset and software which offer three distinct VR scenario choices. We hypothesize that VR immersion will reduce the need for intraoperative pharmacological sedation. Secondary objectives include assessing the tolerance of patients to the VR headset, examining the impact of the chosen VR scenario on the primary outcome, evaluating the incidence of adverse effects, measuring patient satisfaction, and analyzing the output of the Nociception Level (NOL) Index among awake surgical patients.<h4>Materials and methods</h4>This single center randomized controlled trial will enroll 100 patients aged 18 or above undergoing breast surgery under PV block. Participants will be randomly allocated to the VR group or the control group; both will have access to pharmacological sedation through patient-controlled sedation (PCS). Participants in the VR group will choose between three different VR scenarios and will be allowed to switch between these scenarios during surgery. The primary outcome will be the time-adjusted and weight adjusted dose of self-administered intraoperative propofol. Secondary outcomes will include patient satisfaction, adverse events, and post-anesthesia care unit length of stay (PACU LOS).<h4>Ethics</h4>This trial has been approved by the regional ethics committee (Comité d'Éthique de la Recherche du CIUSSS de l'Est de l'Île de Montréal) on September 9th, 2024.<h4>Trial registration</h4>ClinicalTrials.gov (July 25th, 2024). Unique protocol ID: 2025-3802. Trial identification number: NCT06522711.
format Article
id doaj-art-57e94abc0f734effb0760123a77e6f73
institution OA Journals
issn 1932-6203
language English
publishDate 2025-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-57e94abc0f734effb0760123a77e6f732025-08-20T02:37:09ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01207e032755510.1371/journal.pone.0327555Virtual reality as a strategy for intra-operatory anxiolysis and pharmacological sparing in patients undergoing breast surgeries: The V-RAPS randomized controlled trial protocol.Joe ZakoNicolas DaccacheJulien BureyAriane ClairouxLouis MorissonPascal Laferrière-Langlois<h4>Introduction</h4>Virtual reality (VR) has increasingly found applications beyond leisure and video games, extending into the field of medicine. Recent studies indicate that VR can effectively reduce anxiety and pain in pediatric patients undergoing uncomfortable medical procedures, such as burn wound care. Yet, VR use in the operating room is still rare, despite a growing trend toward regional anesthesia without general anesthesia; physicians still frequently rely on pharmacological sedation to manage procedural anxiety. By leveraging VR's anxiolytic properties, it may be possible to decrease the need for intravenous (IV) sedation which is associated with risk of adverse events like apnea and hypoxemia and delayed recovery.<h4>Objectives</h4>This study's main objective is to determine the impact of VR on IV sedation requirements in adult patients undergoing breast surgery under paravertebral (PV) block without general anesthesia. We will be using Paperplane Therapeutics' VR headset and software which offer three distinct VR scenario choices. We hypothesize that VR immersion will reduce the need for intraoperative pharmacological sedation. Secondary objectives include assessing the tolerance of patients to the VR headset, examining the impact of the chosen VR scenario on the primary outcome, evaluating the incidence of adverse effects, measuring patient satisfaction, and analyzing the output of the Nociception Level (NOL) Index among awake surgical patients.<h4>Materials and methods</h4>This single center randomized controlled trial will enroll 100 patients aged 18 or above undergoing breast surgery under PV block. Participants will be randomly allocated to the VR group or the control group; both will have access to pharmacological sedation through patient-controlled sedation (PCS). Participants in the VR group will choose between three different VR scenarios and will be allowed to switch between these scenarios during surgery. The primary outcome will be the time-adjusted and weight adjusted dose of self-administered intraoperative propofol. Secondary outcomes will include patient satisfaction, adverse events, and post-anesthesia care unit length of stay (PACU LOS).<h4>Ethics</h4>This trial has been approved by the regional ethics committee (Comité d'Éthique de la Recherche du CIUSSS de l'Est de l'Île de Montréal) on September 9th, 2024.<h4>Trial registration</h4>ClinicalTrials.gov (July 25th, 2024). Unique protocol ID: 2025-3802. Trial identification number: NCT06522711.https://doi.org/10.1371/journal.pone.0327555
spellingShingle Joe Zako
Nicolas Daccache
Julien Burey
Ariane Clairoux
Louis Morisson
Pascal Laferrière-Langlois
Virtual reality as a strategy for intra-operatory anxiolysis and pharmacological sparing in patients undergoing breast surgeries: The V-RAPS randomized controlled trial protocol.
PLoS ONE
title Virtual reality as a strategy for intra-operatory anxiolysis and pharmacological sparing in patients undergoing breast surgeries: The V-RAPS randomized controlled trial protocol.
title_full Virtual reality as a strategy for intra-operatory anxiolysis and pharmacological sparing in patients undergoing breast surgeries: The V-RAPS randomized controlled trial protocol.
title_fullStr Virtual reality as a strategy for intra-operatory anxiolysis and pharmacological sparing in patients undergoing breast surgeries: The V-RAPS randomized controlled trial protocol.
title_full_unstemmed Virtual reality as a strategy for intra-operatory anxiolysis and pharmacological sparing in patients undergoing breast surgeries: The V-RAPS randomized controlled trial protocol.
title_short Virtual reality as a strategy for intra-operatory anxiolysis and pharmacological sparing in patients undergoing breast surgeries: The V-RAPS randomized controlled trial protocol.
title_sort virtual reality as a strategy for intra operatory anxiolysis and pharmacological sparing in patients undergoing breast surgeries the v raps randomized controlled trial protocol
url https://doi.org/10.1371/journal.pone.0327555
work_keys_str_mv AT joezako virtualrealityasastrategyforintraoperatoryanxiolysisandpharmacologicalsparinginpatientsundergoingbreastsurgeriesthevrapsrandomizedcontrolledtrialprotocol
AT nicolasdaccache virtualrealityasastrategyforintraoperatoryanxiolysisandpharmacologicalsparinginpatientsundergoingbreastsurgeriesthevrapsrandomizedcontrolledtrialprotocol
AT julienburey virtualrealityasastrategyforintraoperatoryanxiolysisandpharmacologicalsparinginpatientsundergoingbreastsurgeriesthevrapsrandomizedcontrolledtrialprotocol
AT arianeclairoux virtualrealityasastrategyforintraoperatoryanxiolysisandpharmacologicalsparinginpatientsundergoingbreastsurgeriesthevrapsrandomizedcontrolledtrialprotocol
AT louismorisson virtualrealityasastrategyforintraoperatoryanxiolysisandpharmacologicalsparinginpatientsundergoingbreastsurgeriesthevrapsrandomizedcontrolledtrialprotocol
AT pascallaferrierelanglois virtualrealityasastrategyforintraoperatoryanxiolysisandpharmacologicalsparinginpatientsundergoingbreastsurgeriesthevrapsrandomizedcontrolledtrialprotocol